SCHEMBL25546406

SCHEMBL25546406

CCc1sc(Cl)nc1-c1cccc(OCCOC)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.40
CHEK2 O96017 1/20 0.40
IGF1R P08069 1/20 0.40
KDM4E B2RXH2 2/20 0.40
ATP4A P20648 2/20 0.40
ATP4B P51164 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
POLQ O75417 1/20 0.39
CYP1A2 P05177 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP19A1 P11511 1/20 0.38
CYP2C9 P11712 1/20 0.38
ALDH1A1 P00352 3/20 0.38
MAPT P10636 2/20 0.38
DHFR P00374 2/20 0.38
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37
PIK3CD O00329 1/20 0.37
NOTUM Q6P988 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25546008 0.87 IGF1R (0.39) CHEK1CHEK2IGF1RKDM4ESMN1; SMN2
SCHEMBL25546364 0.87 FBP1 (0.45) CHEK1CHEK2IGF1RKDM4ESMN1; SMN2
SCHEMBL25546356 0.79 KDM4E (0.46) KDM4ESMN1; SMN2CYP1A2CYP2C19CYP19A1
SCHEMBL25546513 0.78 SMN1; SMN2 (0.47) KDM4EATP4AATP4BSMN1; SMN2CYP1A2
SCHEMBL25546340 0.78 NOTUM (0.46) KDM4ESMN1; SMN2ALDH1A1MAPTHPGD
SCHEMBL25546032 0.76 KMT2A (0.47) KDM4ESMN1; SMN2ALDH1A1MAPTHPGD
SCHEMBL25545940 0.76 NOTUM (0.44) KDM4ESMN1; SMN2ALDH1A1MAPTHPGD
SCHEMBL25546355 0.75 FBP1 (0.42) KDM4ESMN1; SMN2CYP1A2CYP2C19CYP19A1
SCHEMBL25558584 0.74 FBP1 (0.43) CHEK1CHEK2IGF1RKDM4ESMN1; SMN2
SCHEMBL25188877 0.73 KDM4E (0.43) CHEK2KDM4EALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF EIF4E, EIF4EBP1, EIF4A1 CHEK1 1857/4885CHEK2 1736/4885IGF1R 3089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.